Clinical Trial Update: Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer) [Phase 2]

View source ↗

Summary

Phase 2 results for docetaxel in recurrent or persistent endometrial cancer have been reported. The study, sponsored by the Gynecologic Oncology Group, has reac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Taxotere (docetaxel)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Endometrial Cancer | Phase 2 | Status: COMPLETED